Prenatal exome sequencing, a powerful tool for improving the description of prenatal features associated with genetic disorders
- PMID: 39138116
- DOI: 10.1002/pd.6623
Prenatal exome sequencing, a powerful tool for improving the description of prenatal features associated with genetic disorders
Abstract
Objective: Prenatal exome sequencing (pES) is now commonly used in clinical practice. It can be used to identifiy an additional diagnosis in around 30% of fetuses with structural defects and normal chromosomal microarray analysis (CMA). However, interpretation remains challenging due to the limited prenatal data for genetic disorders.
Method: We conducted an ancillary study including fetuses with pathogenic/likely pathogenic variants identified by trio-pES from the "AnDDI-Prenatome" study. The prenatal phenotype of each patient was categorized as typical, uncommon, or unreported based on the comparison of the prenatal findings with documented findings in the literature and public phenotype-genotype databases (ClinVar, HGMD, OMIM, and Decipher).
Results: Prenatal phenotypes were typical for 38/56 fetuses (67.9%). For the others, genotype-phenotype associations were challenging due to uncommon prenatal features (absence of recurrent hallmark, rare, or unreported). We report the first prenatal features associated with LINS1 and PGM1 variants. In addition, a double diagnosis was identified in three fetuses.
Conclusion: Standardizing the description of prenatal features, implementing longitudinal prenatal follow-up, and large-scale collection of prenatal features are essential steps to improving pES data interpretation.
Trial registration: ClinicalTrials.gov NCT03964441.
© 2024 The Author(s). Prenatal Diagnosis published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000‐13, with projections to inform post‐2015 priorities: an updated systematic analysis. Lancet. 2015;385(9966):430‐440. https://doi.org/10.1016/s0140‐6736(14)61698‐6
-
- Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta‐analysis. Ultrasound Obstet Gynecol. 2013;41(6):610‐620. https://doi.org/10.1002/uog.12464
-
- Mellis R, Oprych K, Scotchman E, Hill M, Chitty LS. Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: a systematic review and meta‐analysis. Prenat Diagn. 2022;42(6):662‐685. https://doi.org/10.1002/pd.6115
-
- Tran Mau‐Them F, Delanne J, Denommé‐Pichon AS, et al. Prenatal diagnosis by trio exome sequencing in fetuses with ultrasound anomalies: a powerful diagnostic tool. Front Genet. 2023;14:1099995. https://doi.org/10.3389/fgene.2023.1099995
-
- Normand EA, Braxton A, Nassef S, et al. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder. Genome Med. 2018;10(1):74. https://doi.org/10.1186/s13073‐018‐0582‐x
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous